Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Invested Capital (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) reported Invested Capital of $4.81 billion for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 1.4% from $4.74 billion a year earlier but down 1.2% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Invested Capital (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories posted Invested Capital of $4.85 billion, up 8.0% from FY2025.

  • Invested Capital has increased for six consecutive fiscal years, with a five-year compound annual growth rate of 11.8% (FY2021 to FY2026).
  • By fiscal year, Invested Capital came in at $4.49 billion in FY2025 (+24.7%), $3.61 billion in FY2024 (+21.1%), $2.98 billion in FY2023 (+0.6%) and $2.96 billion in FY2022 (+6.4%).
  • Five-year quarterly Invested Capital spans a low of $2.8 billion in fiscal Q2 2023 and a high of $5.01 billion in fiscal Q3 2026.
  • Year over year, Invested Capital has now increased in each of the last 15 quarters, with growth averaging 13.5% over the last eight quarters.
  • The high point for year-over-year Invested Capital in five years was fiscal Q2 2025 (growth of 32.8%); the low point was fiscal Q2 2023 (a decline of 3.2%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $4.86 billion (Q1 2027), $4.85 billion (Q4 2026) and $5.01 billion (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 126.18 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 76.32 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 39.85 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 151.97 Bn
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn 4.81 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.81 Bn
Jun 30, 2026 4.86 Bn
Mar 31, 2026 4.85 Bn
Dec 31, 2025 5.01 Bn
Sep 30, 2025 4.74 Bn
Jun 30, 2025 4.77 Bn
Mar 31, 2025 4.49 Bn
Dec 31, 2024 4.36 Bn
Sep 30, 2024 4.27 Bn
Jun 30, 2024 3.91 Bn
Mar 31, 2024 3.60 Bn
Dec 31, 2023 3.51 Bn
Sep 30, 2023 3.22 Bn
Jun 30, 2023 3.15 Bn
Mar 31, 2023 2.98 Bn
Dec 31, 2022 2.93 Bn
Sep 30, 2022 2.80 Bn
Jun 30, 2022 2.91 Bn
Mar 31, 2022 2.96 Bn
Dec 31, 2021 2.94 Bn
API Access

Dr Reddys Laboratories Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=RDY&period=max&api_key=YOUR_API_KEY